Over 12 months, Neumora Therapeutics, Inc. saw more buying than selling from its insiders — purchases of about $15 million against sales of $1.1 million.
The largest purchase came from Burow Kristina (Director), about $5 million.
113 investment managers listed NMRA in their latest 13F filings (Q2 2026); more funds bought than sold. Zooming out by quarter: Last full quarter: net selling by insiders. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Aurora Daljit Singh | Officer | Sell | 66,711 | $1.51 | $101K | SEC |
| Aug 21, 2026 | Aurora Daljit Singh | Officer | Sell | 67,741 | $1.51 | $102K | SEC |
| Aug 21, 2026 | Aurora Daljit Singh | Officer | Sell | 20,553 | $1.59 | $33K | SEC |
| Aug 21, 2026 | Aurora Daljit Singh | Officer | Sell | 21,055 | $1.60 | $34K | SEC |
| Aug 19, 2026 | Aurora Daljit Singh | Officer | Sell | 30,918 | $1.65 | $51K | SEC |
| Aug 19, 2026 | Aurora Daljit Singh | Officer | Sell | 31,000 | $1.65 | $51K | SEC |
| Aug 19, 2026 | Aurora Daljit Singh | Officer | Sell | 34,987 | $1.59 | $56K | SEC |
| Aug 19, 2026 | Aurora Daljit Singh | Officer | Sell | 34,162 | $1.58 | $54K | SEC |
| Aug 19, 2026 | Aurora Daljit Singh | Officer | Sell | 55,016 | $1.50 | $83K | SEC |
| Aug 19, 2026 | Aurora Daljit Singh | Officer | Sell | 57,670 | $1.51 | $87K | SEC |
| Aug 19, 2026 | Aurora Daljit Singh | Officer | Sell | 34,020 | $1.49 | $51K | SEC |
| Feb 19, 2026 | Aurora Daljit Singh | Officer | Sell | 6,165 | $3.56 | $22K | SEC |
| Feb 19, 2026 | Pinto Joshua | President | Sell | 5,967 | $3.54 | $21K | SEC |
| Feb 19, 2026 | BERNS PAUL L | Officer | Sell | 9,819 | $3.51 | $34K | SEC |
| Feb 19, 2026 | Milligan Michael Lee | Officer | Sell | 1,436 | $3.57 | $5K | SEC |
In the last 12 months Neumora Therapeutics, Inc. insiders made open-market purchases worth about $15 million and sales worth about $1.1 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in NMRA was filed on 2026-08-21.
113 investment managers reported holding NMRA in SEC Form 13F filings for Q2 2026.
No congressional trades in NMRA were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).